Tilactase - Pro Farma

Drug Profile

Tilactase - Pro Farma

Alternative Names: Beta-D-galactosidase; Lacdigest

Latest Information Update: 02 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pro Farma
  • Developer MN Pharmaceuticals; Recordati
  • Class Galactosidases
  • Mechanism of Action Enzyme replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Lactose intolerance

Most Recent Events

  • 10 Jul 2009 Launched for Lactose intolerance in Turkey (PO) after July 2009
  • 10 Jun 2009 Registered for Lactose intolerance in Turkey (PO) (MN Pharmaceuticals website, August 2016)
  • 31 Mar 2009 Launched for Lactose intolerance in Italy (PO) after March 2009
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top